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Abstract
Background: Glaucoma is a major blinding disease. The most common form of this disease, primary open angle glaucoma
(POAG), is genetically heterogeneous. One of the candidate genes, optineurin, is linked principally to normal tension
glaucoma, a subtype of POAG. The present study was undertaken to illustrate the basic characteristics of optineurin.
Methodology/Principal Findings: Lysates from rat retinal ganglion RGC5 cells were subjected to N- or O-deglycosylation or
membrane protein extraction. The phosphorylation status was evaluated after immunoprecipitation. It was found that while
phosphorylated, optineurin was neither N- nor O-glycosylated, and was by itself not a membrane protein. RGC5 and human
retinal pigment epithelial cells were double stained with anti-optineurin and anti-GM130. The endogenous optineurin
exhibited a diffuse, cytoplasmic distribution, but a population of the protein was associated with the Golgi apparatus.
Turnover experiments showed that the endogenous optineurin was relatively short-lived, with a half-life of approximately
8 hours. Native blue gel electrophoresis revealed that the endogenous optineurin formed homohexamers. Optineurin also
interacted with molecules including Rab8, myosin VI, and transferrin receptor to assemble into supermolecular complexes.
When overexpressed, optineurin–green fluorescence protein (GFP) fusion protein formed punctate structures termed ‘‘foci’’
in the perinuclear region. Treatment of nocadazole resulted in dispersion of the optineurin foci. In addition, tetracycline-
regulated optineurin-GFPs expressing RGC5 stable cell lines were established for the first time.
Conclusions/Significance: The present study provides new information regarding basic characteristics of optineurin that
are important for future efforts in defining precisely how optineurin functions normally and how mutations may result in
pathology. The inducible optineurin-GFP–expressing cell lines are also anticipated to facilitate in-depth studies of
optineurin. Furthermore, the demonstrations that optineurin is an aggregation-prone protein and that the foci formation is
microtubule-dependent bear similarities to features documented in neurodegenerative diseases, supporting a
neurodegenerative paradigm for glaucoma.
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Introduction
Glaucoma, one of the leading causes of irreversible blindness
worldwide [1], is characterized by progressive loss of retinal
ganglion cells (RGCs) and axons, as well as distinctive cupping of
the optic nerve head. The most common form of this disease,
primary open angle glaucoma (POAG), is age-related and is
frequently associated with elevated intraocular pressure.
Recent studies have demonstrated that POAG is genetically
heterogeneous, caused by several susceptibility genes and perhaps
also environmental factors [1–4]. Currently, a total of 14
chromosomal loci, designated as GLC1A to GLA1N, have been
linked to POAG. Three candidate genes identified within these loci
include myocilin (GLC1A), optineurin (GLC1E), and WD40-
repeat36 (WDR36, GLC1G) [1–3]. Among them, optineurin is
linked principally to normal pressure or normal tension glaucoma
[5], a subtype of POAG. Optineurin mutations were noted to vary
with ethnic background [6]. The Glu50Lys (E50K) mutation, found
in Caucasian and Hispanic populations [6], seems to be associated
with a more progressive and severe disease in normal tension
glaucoma patients [7].
The human optineurin gene codes for a 577-amino acid protein
that contains multiple coiled-coil domains and a C-terminal zinc
finger [8]. The optineurin protein from different species has high
amino acid homology [9] and the amino acid 50 glutamic acid
residue is conserved in mouse, rat, chicken and cow [10].
Optineurin is ubiquitously expressed in non-ocular tissues such as
the heart and brain [8] and in ocular tissues including the retina,
trabecular meshwork, and non-pigmented ciliary epithelium [9]. In
the retina, RGCs are immunolabeled with high intensity [10,11].
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(NF-kB essential modulator) and was identified as a NEMO-
related protein [12]. In murine pre-B and mouse T-cell hybridoma
cell lines, optineurin expression was upregulated by tumor necrosis
factor a (TNFa) and interferon and its phosphorylation was
induced upon phorbol 12-myristate 13-acetate (PMA) stimulation
[12]. More recently, optineurin has been shown to be a negative
regulator of NF-kB [13]. There appears to be a negative feedback
loop; the optineurin promoter activity and gene expression are
elevated by treatment of TNF-a via the NF-kB pathway, and the
optineurin induced in turn inhibits the NF-kB activation,
dampening the TNFa signaling [13,14].
Optineurin has in addition been shown to interact with
transcription factor IIIA [15], Rab8 [16–20], huntingtin [16],
myosin VI [17–19], metabotropic glutamate receptor [21], and
TANK-binding kinase 1 [22]. It has been noted that optineurin
may form complexes with Rab8 and myosin VI [17–20],
mediating the targeting of myosin VI to the Golgi complex and
may be involved in organization of the Golgi apparatus [17,18].
siRNA studies also suggested a role of optineurin in the exocytosis
of vesicular-stomatitis-virus G protein [18].
Despite these efforts, there is a surprisingly lack of data
regarding the fundamental properties of optineurin protein. It is
still unclear, for example, whether optineurin is itself associated
with membranes, whether it is glycosylated, or whether it is in-
deed localized to the Golgi apparatus. Also there has been no
illustration so far as to the phosphorylation status of optineurin.
Neither has direct evidence been provided that optineurin forms
complex with interacting proteins.
The present investigation was undertaken to elucidate the basic
characteristics of optineurin in RGC5 and retinal pigment
epithelial (RPE) cells. Specifically, the glycosylation and phos-
phorylation status, the possible Golgi localization, the membrane
association, and the turnover rate of optineurin were investigated.
The oligomerization of optineurin with itself, and the complex
formation with Rab8, myosin VI, and transferrin receptor (TfR)
were demonstrated for the fist time. In addition, optineurin was
found to accumulate to form granular structures or foci in
perinuclear regions when overexpressed and the foci formation
was microtubule dependent.
Results
Glycosylation and Phosphorylation of Optineurin
From GenBank’s reference sequence of human optineurin, the
predicted molecular weight is 65921.9. However, on sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and by Western blotting, we consistently detected the endogenous
optineurin at a higher, 74 kDa molecular size. The difference
between the actual and predicted molecular weight led us to
suspect that optineurin is posttranslationally modified.
Several potential N-glycosylation sites were predicted for both
human and rat sequences using the NetNGlyc 1.0 Server (http://
www.cbs.dtu.dk/services/NetNGlyc/). One potential O-glycosyl-
ation site (202 T) was predicted in human optineurin using
the DictyOGlyc 1.1 Server (http://www.cbs.dtu.dk/services/
DictyOGlyc/). Lysates from RGC5 cells were treated with peptide
N-glycosidase F (PNGase F, for N-deglycosylation) or O-
glycosidase (for O-deglycosylaton) without or with a-2(3,6,8,9)-
neuraminidase (sialidase), and Western blotted for optineurin. The
band pattern of optineurin (Fig. 1A and B, left panel) was found
not affected by any of these enzyme treatments. In parallel, the
positive controls, ribonuclease B (RNase B) and fetuin, showed a
band shift after N- or O-deglycosylation respectively (Fig. 1A and
B, right panel). The former shifted from 17 to 15 kDa and the
latter from 64 to 55 kDa with O-glycosidase and sialidase
treatment. Fetuin was resistant to single O-glycosidase digestion
due to the fact that its N-linked and O-linked oligosaccharides are
sialylated [23]. A similar lack of glycosylation result was also
obtained using lysates from RGC5 cells transfected with pTarget-
FLAG-optineurin (OPTN) (Fig. 1A and 1B).
There is one site predicted (amino acid residue 356 for human
and 361 for rat) in the optineurin sequence for tyrosine
phosphorylation, 11 for threonine phosphorylation and at least
19 sites predicted for serine phosphorylation (NetPhos 2.0 Server).
Phosphorylation experiment showed that optineurin immunopre-
cipitated from RGC5 lysates was immunoreactive against anti-
phosphoserine and anti-phosphotyrosine (Fig. 1C), but not toward
anti-phosphothreonine (data not shown). Immunoprecipitated pull
down was verified by immunoblotting with anti-optineurin (anti-
OPTN, Fig. 1C right panel).
Localization of the Endogenous Optineurin
RGC5 cells were double stained with anti-C-terminal opti-
neurin and anti-GM130. The endogenous optineurin exhibited a
diffuse cytoplasmic distribution pattern when 0.1 M glycine was
included in the PBS rinsing buffer (Fig. 2A, top panels). With-
out glycine, the cytoplasmic staining was diminished and the
optineurin appeared to be distributing more prominently in the
perinuclear region, overlapping and colocalizing with the Golgi
marker GM130 (Fig. 2A, bottom panels). Blocking by either 3%
BSA or 10% normal goat serum made little difference in the
optineurin staining patterns (photos not shown). Cells incubated
with only secondary antibodies as negative controls showed no
staining.
The optineurin localization in human RPE cells was re-
examined. Previously, using anti-INT optineurin antibody and
glycine-containing rinsing solution, it was noted that the
endogenous optineurin had a diffuse staining pattern displaying
little colocalization with the Golgi apparatus in human RPE and
trabecular meshwork cells [17]. The new set of immunostaining
was performed using both anti-C-terminal- and anti-INT-
optineurin antibodies. It was found that anti-INT-optineurin
yielded a diffuse, cytoplasmic staining with or without the glycine
rinse (Fig. 2B). When anti-C-terminal optineurin was used, the
staining pattern in RPE cells remained diffuse with, whereas it
became more Golgi-associated without, the glycine wash (Fig. 2B).
Optineurin Is Not a Membrane Protein
To determine whether optineurin itself is a membrane protein,
lysates of RGC5 cells were subjected to membrane protein
extraction. Proteins in the hydrophilic and hydrophobic fractions
were immunoblotted with anti-C-terminal-optineurin and anti-
GM130. The endogenous optineurin was seen to distribute
exclusively in the hydrophilic fraction (Fig. 2C). GM130, used as
positive control membrane protein, was predominantly detected in
the hydrophobic fraction as expected (Fig. 2C).
Optineurin Foci Formation upon Forced Exogenous
Overexpression
When transfected with pEGFP-N1 (mock control), fluorescence
from the expressed green fluorescence protein (GFP) was observed
in the entire RGC5 cells including the nucleus (Fig. 3A, top left
panel). When transfected with pOPTN-EGFP plasmid, diffuse
green fluorescence from optineurin-GFP fusion protein was also
seen in the cytoplasm of RGC5 cells. In addition, bright granular
or punctuate structures in the perinuclear regions were noted
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PLoS ONE | www.plosone.org 2 February 2010 | Volume 5 | Issue 2 | e9168Figure 1. Optineurin is neither N- (A) nor O- (B) glycosylated but is phosphorylated (C). Lysates from RGC5 cells or those transfected with
pOPTN-FLAG were untreated (control), or treated with PNGase F (for N-deglycosylation, A) or O-glycosidase (for O-deglycosylation) without (B)o r
with sialidase (not shown). The digested samples were subjected to Western blotting using anti-optineurin. The band pattern of optineurin (A and B,
left panel) was not affected by any of the enzyme treatments. By Coomassie blue staining, the purified RNase B, as a positive control, had a band shift
from 17 to 15 kDa after N-deglycosylation (A, right panel). The purified fetuin had a band shift from 64 to 55 kDa (B, right panel) after O-glycosidase
and sialidase digestion. Fetuin was resistant to a single O-glycosidase digestion due to the fact that its N-linked and O-linked oligosaccharides are
sialylated. C. Lysates from RGC5 cells were immunoprecipitated with either rabbit anti-C-terminal optineurin polyclonal antibody (IP OPTN) or normal
rabbit IgG as an IP negative control (IP Control)) and were then immunoblotted with mouse anti-phosphotyrosine (anti-phosphoTyr), anti-mouse
phosphoserine (anti-phosphoSer), or anti-C-terminal optineurin (anti-OPTN). The anti-optineurin but not rabbit IgG immunoprecipitated proteins
were immunoreactive toward anti-phosphotyrosine (left panel) and anti-phosphoserine (middle panel). No immunoreactivity was observed with anti-
phosphothreonine (not shown). Lysate from A431 (human epithelial carcinoma) cell line was used a positive control in anti-phosphotyrosine
experiments. Immunoprecipitated pull down was verified by immunoblotting with anti-optineurin (anti-OPTN, right panel). Size markers are
indicated. Arrows denote the 74-kDa optineurin band.
doi:10.1371/journal.pone.0009168.g001
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PLoS ONE | www.plosone.org 3 February 2010 | Volume 5 | Issue 2 | e9168Figure 2. The endogenous optineurin is localized partially to the Golgi apparatus but is not a membrane protein. A. RGC5 cells were
double immunostained with anti-C-terminal optineurin (in green) and anti-GM130 (Golgi marker, in red). The endogenous optineurin (OPTN) had a
diffuse cytoplasmic distribution pattern when 0.1 M glycine was included in the PBS rinsing buffer (top, left panel). Without glycine (bottom, left
panel), the optineurin staining was prominent in the perinuclear region, colocalizing (in yellow, Merged) with the Golgi apparatus. Cells incubated
with only secondary antibodies as negative controls (NC) showed no staining (right panels). B. Human RPE cells were immunostained with anti-C-
terminal (Anti-C-term, in green) or anti-INT (Anti-INT, in green) optineurin along with anti-GM130 (in red). The endogenous optineurin (OPTN) had a
diffuse cytoplasmic distribution pattern when anti-INT optineurin antibody was used (middle right panels) regardless whether glycine was includedi n
the initial rinse. Using anti-C-terminal antibody, the optineurin staining was more perinuclar and Golgi-associated without the glycine rinse (left
panels). Cells incubated with only secondary antibodies as negative controls (NC) showed minimal staining (right panels). The nuclei were stained
with DAPI in blue. Scale bar, 10 mm. C. Western blot analyses of hydrophilic and hydrophobic fractions from RGC5 cell lysates. Total proteins in RGC
lysates were subjected to membrane protein extraction. The hydrophilic fraction (left lane) contained predominantly non-membrane cytosolic
proteins and the hydrophobic fraction (right lane) contained membrane proteins. Optineurin (OPTN) was detected exclusively in the hydrophilic
fraction. GM130, a Golgi marker used as membrane protein positive control, was detected in the hydrophobic fraction as expected.
doi:10.1371/journal.pone.0009168.g002
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those termed foci found previously in RPE cells [17]. Live cell
imaging indicated that the foci were not stationary. They fused
with or separated from each other (Video S1) and were mobile,
sometimes exhibiting long distance movements (Video S2). When
immunostained with Golgi marker GM130 in red (Fig. 3A, right
panels), the optineurin foci in RGC5 cells did not colocalize with
the Golgi apparatus (Fig. 3A, insert, bottom right panel). The lack
of major colocalization, confirmed by confocal microscopy after
sequential scanning, was also demonstrated previously in human
RPE and trabecular meshwork cells [17]. Golgi fragmentation
(Fig. 3A, arrow) was in addition noted in all these cell types [17].
Neurites were formed in RGC5 cells following treatment of
staursporine [24]. In the differentiated, pOPTN-EGFP-transfeced
RGC5 cells, punctate optineurin-GFP foci were found on the
neurite extensions (Fig. 3B). Immunofluorescence of differentiated,
nontransfected RGC5 cells also confirmed the presence of
endogenous optineurin in neurites (data not shown).
Distribution of Optineurin Foci Is Microtubule Dependent
The long distance movement of optineurin foci (Video S2)
suggested that their distribution might depend on the microtubule
network. pOPTN-EGFP-transfected RGC5 (Fig. 4A) and RPE
(Fig. 4B) cells were treated with nocadazole, an agent that
interferes with microtubule polymerization. Disruption of the
network by nocadazole was confirmed by a-tubulin staining (Fig. 4)
and under this condition, the optineurin foci were dispersed from
the perinuclear region to distribute evenly in the cytoplasm. When
nocadazole was removed, the microtubule was recovered and the
optineurin foci were again clustered around the perinuclear
region, similar to that seen in the untreated controls.
Oligomerization of Optineurin
The secondary structure prediction based on the amino acid
sequence of both human and rat optineurin showed that it is rich
in a-helical coils (,68%) (http://npsa-pbil.ibcp.fr/cgi-bin/
npsa_automat.pl?page=npsa_gor4.html and http://www.russell.
embl.de/cgi-bin/coils-svr.pl), which supercoil to form protein-
protein interaction coiled coil domains [25]. To examine the
possibility that optineurin can form oligomers or complexes,
lysates from RGC5 cells were run on native blue gels followed by
Western blotting for the endogenous optineurin under non-
reducing conditions. A single band was detected at approximately
420-kDa, mass equivalent of homo-hexamer, indicating that
optineurin interacted with itself to form hexamers (Fig. 5A, left
lane).
Lysates from RGC5 cells transfected to express FLAG-
optineurin fusion protein were also subjected to native blue gel
electrophoresis and Western blotting. The 420 kDa-band was
likewise observed using anti-FLAG (Fig. 5A, right lane). In
addition, higher molecular weight bands which might represent
complexes formed between FLAG-optineurin and other opti-
neurin binding partners were also seen.
Co-immunoprecipitation (IP) experiments further proved that
optineurin monomer could interact with another monomer to
form complex. RGC5 cells were co-transfected to express N-
terminal FLAG-tagged optineurin and C-terminal histidine (His)-
tagged-optineurin. Thereafter, optineurin-His was pulled down
with rabbit polyclonal anti-His antibody, and the pull down was
immunoblotted under reducing conditions with mouse monoclo-
nal anti-FLAG. As shown in Fig. 5B, the immunoprecipitate was
immunoreactive to anti-FLAG (left lane). When normal rabbit IgG
was used as the IP negative control (right lane), the FLAG-
optineurin band (,74 kDa, arrowhead) was not detected.
Interaction of Optineurin with Other Proteins
Optineurin foci have been shown to colocalize, at least partially,
with Rab8, myosin VI, and TfR in human RPE cells [17]. Such a
result was reproduced in RGC5 cells (Fig. 6A). To investigate
complex formation, RGC5 cells were co-transfected with pTarget-
FLAG-OPTN and pRab8Q67L-GFP, pMyoVI-EGFP, and/or
pTfR-EGFP in various combinations. By native blue gel
electrophoresis and Western blotting, FLAG-optineurin was found
to assemble into super molecular complexes with Rab8, myosin
VI, and TfR (Fig. 6B). The molecular sizes of the complexes were
larger than 400 kDa while monomer FLAG-optineurin could also
be visualized in some of the combinations. The strongest complex
formation appeared to be between FLAG-optineurin and myosin
VI. It was somewhat reduced when Rab8Q67L and/or TfR was
present. When all four proteins were expressed in the cells, the
Figure 3. Cellular localization of overexpressed wild type
optineurin. A. RGC5 cells were transfected for 20 h, fixed and
immunostained. When transfected with pEGFP-N1 (mock control, top,
left panel), green fluorescence was observed in the entire RGC5 cells
including the nucleus. When transfected with pOPTN-EGFP (OPTN-GFP,
bottom, left panel), diffuse green fluorescence was likewise seen in the
cytoplasm of RGC5 cells. In addition, bright granular or punctuate
structures termed foci were also noted in the perinuclear region around
the Golgi apparatus (stained with anti-GM130 in red). Insets show the
enlarged and merged images in the perinuclear region. Optineurin foci
largely did not overlap with the GM130 staining. Golgi fragmentation in
pOPTN-EGFP-transfected cells (arrows) was observed. Scale bar, 10 mm.
B. RGC5 cells were transfected with pOPTN-EGFP for 20 h and
underwent differentiation with treatment of 316 nM staurosporine for
4 h. Punctate optineurin-GFP foci (green) were found on the neurite
extensions (arrowheads). The enlarged and amplified image of the
blocked area is shown in the right panel. Scale bars, 10 mm.
doi:10.1371/journal.pone.0009168.g003
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were also found in RPE cells (data not shown).
Establishment of Optineurin-GFP Tetracycline Regulated
(Tet-on) RGC5 Stable Cell Lines
The inducible Tet-on optineurin-GFP expressing RGC5 stable
cell lines were established using a single plasmid vector pTRE-
OPTN-EGFP-INS-rtTA-IRES-hyg-pcDNA3.1z which contains
both tetracycline regulatory and responsive components based
on Clontech’s Tet-on advance system. When transfected into
RGC5 cells, optineurin-GFP was expressed upon doxycycline
(Dox) induction.
After several rounds of selection, two clones of the inducible
cells lines were obtained. One, the low expresser, exhibited a faint,
while the other, the high expresser, showed a strong, green
fluorescence after Dox induction (Fig. 7A). Western blotting also
confirmed that the induced level of optineurin-GFP was low in the
former but high in the latter (Fig. 7B). Microscopic examination of
these stable cell lines indicated that the distribution of optineurin-
GFP in the low expressers mimicked that of the endogenous
optineurin, displaying a more spread out, cytoplasmic pattern
whereas that in the high expresser mimicked what was seen in
transfected cells, with foci observed in the perinuclear region.
Turnover of Optineurin Protein
To study the turnover of the endogenous optineurin, RGC5
cells were treated with 5 mg/ml of cycloheximide for 4 h to block
the protein synthesis, and were chased for 0, 2, 4, 6, 8, and 24 h.
The level of the endogenous optineurin, judged by Western
blotting, was decreased with time (Fig. 8A). The half life of the
endogenous optineurin was calculated to be approximately 8 h.
To study the turnover of the overexpressed optineurin-GFP, the
low and the high expresser clones were induced by Dox for 20 h,
treated with cycloheximide, and chased for 0, 4, 8, 16, 24 and
Figure 4. Distribution of optineurin foci is microtubule dependent. RGC5 (A) and RPE (B) cells expressing optineurin-GFP (OPTN-GFP) were
untreated (Control) or treated with 10 mM nocodazole for 30 min. The cells were washed thoroughly to remove nocodazole (Washout) and allowed
to recover for 1 h. The optineurin-GFP foci appeared in green and the microtubule network was visualized by immunostaining with anti-a-tubulin in
red. The microtubule was disrupted upon nocodazole treatment and the optineurin foci were dispersed from perinuclear region to distribute evenly
in the cytoplasm. Upon nocadazole removal, the microtubule network was restored and the foci returned to the perinuclear area. Scale bar, 10 mm.
doi:10.1371/journal.pone.0009168.g004
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optineurin-GFP still remained even after 40 h. The half life was
approximately 20 h in the low expressers (Fig. 8B). The higher the
optineurin-GFP expression, the more decelerated the degradation
and the more prolonged was the half life (compare Fig. 8C versus
8B). The processing of the endogenous optineurin was also
affected in the high expressers (Fig. 8C).
Discussion
The present study provides information regarding basic
characteristics of optineurin that are of fundamental importance.
These properties have not been clearly illustrated previously in the
literature. As one example, while potential glycosylation sites are
predicted by computer analysis [26], it was never certain whether
optineurin is a glycosylated protein. The current investigation is
hence the first to establish that optineurin is neither N- nor O-
glycosylated (Fig. 1A and B). In the field of optineurin, there was a
controversy as to whether optineurin is secreted. Rezaie et al. [5]
reported that optineurin was found in the aqueous humor and also
in the culture medium, suggesting that it might be a secreted
protein. However, a secretion assay conducted in our laboratory
showed that optineurin is not secreted [17]. The lack of
glycosylation demonstrated herein accords with the prediction
that optineurin may not contain a signal peptide (http://www.cbs.
dtu.dk/services/SignalP/) and provides support that optineurin is
not a secreted protein. Both N-glycosylation and signal peptide
sequences are documented to be crucial factors controlling
constitutive protein secretion [27,28].
In 2000, Schwamborn et al. [12] noted that the optineurin band
was upshifted upon PMA treatment in E29.1 T cells, implying that
optineurin might be phosphorylated, but the factual phosphory-
lation status was not addressed. Here we show that optineurin is
serine- and tyrosine-, but not threonine-phosphorylated (Fig. 1C).
Phosphorylation often introduces conformational changes and
makes proteins more hydrophilic. In general, phosphorylation of
proteins on serine, threonine and/or tyrosine is one of the
significant regulatory mechanisms in gene expression and
posttranslational modifications in both eukaryotes and prokary-
otes. The phosphorylation status is known to be important for
protein protein interaction and protein degradation. Tyrosine
phosphorylation in particular has been recognized as a key means
of signal transduction, implicated in cell growth, metabolic
regulation and differentiation [29,30]. A possibility of optineurin
involvement in signal transduction may exist.
There have also been conflicting results as to optineurin’s
cellular localization at the Golgi apparatus. In a paper by Au et al.
[31], it was somewhat vaguely stated that ‘‘optineurin appears to
be a linker protein between myosin VI and Rab8, as all three
proteins colocalize in the perinuclear region at/around the Golgi
complex…’’. Our immunostaining experiments provided clarifi-
cations that different staining patterns may result depending on the
antibodies and washing procedures used. Two commercially
available antibodies, anti-C-terminal- and anti-INT-optineurin,
were tested. The former is reactive to human, mouse and rat
optineurin while the latter is reactive only to the human protein.
In both rat RGC5 and human RPE cells (Fig. 2), a diffuse,
cytoplasmic distribution pattern of optineurin resulted when they
were washed in glycine-containing solution and stained with anti-
C-terminal-optineurin antibody. When glycine was omitted in the
rinse, the cytoplasmic staining was low and optineurin seemed to
locate largely in the perinuclear area overlapping with the Golgi
marker GM130. Glycine has been used previously for antigen
retrieval purposes [32]. Inclusion of glycine in the rinse might have
uncovered antigen site(s), enhancing the optineurin staining in
the cytoplasm and in turn rendering the Golgi association less
distinctive. Anti-INT-human optineurin antibody, presumably
reactive against epitope(s) different from those of anti-C-terminal
antibody, yielded the diffuse, cytosolic pattern regardless whether
glycine was used for the rinse in human RPE cells (Fig. 2B). We
concluded unambiguously that optineurin has a diffuse, cytoplas-
mic distribution but a population of the protein is associated with
the Golgi apparatus.
Because of the Golgi association, the next question was whether
optineurin is itself a membrane protein. Subsequent experiments
(Fig. 2C) revealed that optineurin is a hydrophilic, cytosolic
protein, consistent with the prediction that the protein sequence
contains no obvious transmembrane domains (http://www.cbs.
dtu.dk/services/TMHMM/). The cytosolic localization of opti-
neurin may accurately reflect its distribution and the role of
optineurin is to interact with other proteins [19]. Sahlender et al.
[18] suggested previously that optineurin may link myosin VI to
Rab8 at the Golgi complex but did not specify or demonstrate
experimentally whether optineurin is the Golgi anchor. Our
findings stipulate that the optineurin-Golgi association is rather
indirect and offer the insight that mostly likely it is Rab8 that
serves as the Golgi anchor for optineurin, which then provides the
next link for myosin VI.
Bright fluorescent granular or punctuate structures termed foci
were observed (Fig. 3) when RGC5 cells were transfected to force
overexpress optineurin-GFP. In agreement with our previous data
Figure 5. Oligomerization of optineurin. A. Native blue gel
electrophoresis. Total protein from RGC5 cells (30 mg) and that (15 mg)
from RGC5 cells transfected for 20 h to express FLAG-optineurin (FLAG-
OPTN) fusion protein were subjected to native blue gel electrophoresis
and Western blotting. The membranes were probed either with anti-
optineurin to detect the endogenous optineurin (left lane) or anti-FLAG
to detect the forced expressed FLAG-OPTN fusion protein (right lane). A
band at approximately 420 kDa was observed in both cases in the
native gel. With the FLAG-OPTN, higher molecular weight bands which
may represent the complex formed with other optineurin binding
partners were additionally seen. B. Co-immunoprecipiation. RGC5 cells
were co-transfected with pTarget-FLAG-OPTN and pOPTN-His. Cell
lysates were immunoprecipitated with rabbit anti-His antibody, and the
immunoprecipitated proteins were probed with anti-FLAG antibody
under reducing conditions. An immuoreactive optineurin band
(arrowhead) was detected in the anti-His (IP His, left lane) but not in
the rabbit IgG (IP Control, right lane) pull down. Size markers are
indicated.
doi:10.1371/journal.pone.0009168.g005
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PLoS ONE | www.plosone.org 7 February 2010 | Volume 5 | Issue 2 | e9168Figure 6. Protein interactions of optineurin. A. Colocalization of optineurin-GFP foci with Rab8, myosin VI (MyoVI) and transferrin receptor (TfR).
RGC5 cells were transfected for 20 h to express optineurin-GFP (OPTN-GFP, in green) and immunostained with anti-Rab8, anti-MyoVI, or anti-TfR.Cy3-
labled secondary antibody was used and the Rab8, MyoVI and TfR staining appeared in red (Cy3). Merged images are presented at the bottom panel.
Colocalization of optineurin foci with Rab8, MyoVI, and TfR was observed in the perinuclear region in yellow in transfected cells. Those cells that
stained positively with anti-Rab8, anti-MyoVI, and anti-TfR in red, but did not display any green fluorescence are non-transfected cells. B. Complex
formation of optineurin with Rab8, MyoVI and TfR. RGC5 cells were co-transfected with p-Target-FLAG-OPTN (FLAG-OPTN) and pRab8Q67L-EGFP
(Rab8Q67L-GFP), pMyoVI-EGFP (MyoVI-GFP), pTfR-EGFP (TfR-GFP), pRab8Q67L-EGFP + pMyoVI-EGFP, pRab8Q67L-EGFP + pTfR-EGFP, pMyoVI-EGFP+ pTfR-
EGFP, or pRab8Q67L-EGFP + pMyoVI-EGFP + pTfR-EGFP. 20 mg of lysates from the transfected cells were subjected to native blue gel electrophoresis
and Western blotting using anti-FLAG antibody. Super complexes with molecular sizes larger than 400 kDa were detected. The strongest complex
formation was observed between FLAG-OPTN and MyoVI. The complex formation between them was reduced when Rab8Q67L and/or TfR was
present. They may compete with each other to interact with optineurin. Size markers are indicated. Arrow denotes the sample loading front.
doi:10.1371/journal.pone.0009168.g006
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also seen in transfected RGC5 cells. The foci, located in the
perinuclear region in close proximity to the Golgi apparatus, are
not overtly associated with the organelle (Fig. 3A). It is of note that
the optineurin foci in transfected RGC5 cells were also found upon
differentiation in neurite extensions (Fig. 3B). Positive immuno-
staining of the endogenous optineurin was likewise observed in
neurites in differentiated, nontransfected RGC5 cells (data not
shown). These new observations suggest a possible physiological
role of optineurin in polarized neurons, although additional studies
are needed to substantiate this notion.
Optineurin has been shown to be present in the native RGCs in
mouse eyes [11]. We also stained human, mouse, and rat retinal
tissues with anti-optineurin, confirming its presence in RGCs
(photographs not shown). The light microscopic examinations
however, did not allow the determination whether optineurin is
located at the Golgi apparatus or in dendritic trees. Immunogold
studies will be necessary for such a determination.
The optineurin foci in transfected cells are likely formed by
interactions of optineurin with itself and also with its interacting
molecules. The self association of optineurin [33] and interaction
between optineurin and Rab8 [16], myosin VI [18], and transferrin
receptor [17,31] have been documented previously via methods
including yeast 2-hybrid and colocalization. In the article by
Sahlender et al. [18], the authors suggested that ‘‘these (colocaliza-
tion) results strongly indicate that myosin VI binds to and form a
protein complex with optineurin in vivo’’. Au et al. [31] stated that
‘‘these results, together with previous data, strongly suggest that
myosin VI, optineurin, and Rab8 operate in the same basolateral
sorting pathway and, most likely, form a functional complex.’’ Yet,
the complex formation between these proteins has never been
verified or experimentally demonstrated. Chalasani et al. [33]
recently in a brief review also noted that ‘‘optineurin self-
oligomerizes but the degree of oligomerization is not yet known’’.
By native blue gel electrophoresis, we supplied evidence that
optineurin is capable of forming 420 kDa homo-oligomers
(Fig. 5A), which, based on the 67 kDa monomer size, is estimated
to be hexamers. The optineurin foci were found to colocalize at
least partially with Rab8, myosin VI, and TfR (Fig. 6A).
Furthermore, optineurin associates with these proteins, either
singly or in combination, to form supermolecular complexes with
sizes larger than 400 kDa (Fig. 6B). There seemed to be also
competitions in interactions with optineurin and we hypothesize
that optineurin may need to be present in the cells in an optimal
level such that all interactions are properly maintained. Distur-
bances of the various interactions, resulting from knock down or
mutation, or when optineurin is in excess, might have pathophys-
iological consequences.
The foci formed by the overexpressed optineurin-GFP are
dynamic structures. Visualized by live cell imaging, they move
around in both short and long ranges (Videos S1 and S2). The
long range movement probably involves the microtubule network.
Subsequent experimentation proved that indeed the formation of
optineurin foci is microtubule dependent (Fig. 4).
Furthermore, our laboratory established, for the first time, Tet-
on inducible RGC5 cells lines using a single plasmid that contains
both the tetracycline regulatory and response components.
Establishment of Tet-on stable cell line normally involves two
steps; first to generate the regulatory stable cell line, which is then
used to produce the response stable cell line. In the regulatory cell
Figure 7. Inducible expression of optineurin-GFP in Tet-on RGC5 stable cell lines. A. Expression of optineurin-GFP by fluorescent
microscope in two clones of the stable cell lines. Upon Dox induction, the low expresser (middle panel) showed a faint level of fluorescence in the
cytoplasm while the high expresser (right panel) displayed bright fluorescence with foci observed in the perinuclear region. Non-induced control with
background level of optineurin-GFP is presented on the left panel. B. Western blotting confirmed the expression of optineurin-GFP (OPTN-GFP) fusion
protein in the low (lane 2) and the high (lane 4) expressers upon Dox induction. The optineurin-GFP band is barely visible without Dox induction (lane
1 for low expresser and lane 3 for high expresser). The endogenous optineurin (endogenous OPTN) band was seen in all 4 lanes. Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was used as a loading control.
doi:10.1371/journal.pone.0009168.g007
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activates transcription from a tetracycline response element as a
consequence of Dox treatment. In the response cell line, the key
component is the gene of interest tightly controlled by a Ptight
promoter. This two-step Tet-on system is not only time consuming
but also reliant on the cell’s sensitivity to at least two different
selection antibiotics. Many ocular cells including RGC5 are very
resistant to various commonly used selection antibiotics, includ-
ing G418, zeocin, and puromycin. Fortunately, RGC5 cells are
sensitive to hygromycin. Taking advantage of this sensitivity and
using a single plasmid which requires only one round of cloning/
selection made it feasible for establishment of the RGC5 stable cell
lines. In this single plasmid, the responsive component is separated
from the regulatory components with the 1.2 kb full length 59-HS4
chicken b-globin insulator (INS) to block the potential cross talk
between two expression cassettes [34–38].
Two constructs were ultimately created, with the two expression
cassettes in either the same or the opposite orientation (Fig. S1).
Both exhibited a low level of basal expression and high sensitivity
to induction. With these constructs, two inducible cell lines were
obtained; one expresses optineurin-GFP at low (low expresser) and
the other at high (high expresser) levels upon Dox induction. In the
low expressers, optineurin-GFP had a diffuse, cytosolic distribution
(Fig. 7), comparable to that seen in the endogenous situation. In
the high expressers, the foci were formed in the perinuclear region
proximal to the Golgi (Fig. 7), similar to that observed in pOPTN-
EGFP-transfected cells (Fig. 3A).
Turnover experiments were performed using RGC5 cells, as
well as the low and high expressers. Previously, Schwamborn et al.
[12] researched the half life of optineurin under PMA treatment.
The investigators examined up to 5.5 h and concluded that
optineurin has a rather long half life and that PMA treatment
decreases its half life. The actual half life estimate however was not
provided. We disclosed that the half life of the endogenous
optineurin is approximately 8 h (Fig. 8A). When optineurin-GFP
was expressed, the half life of the exogenous optineurin-GFP was
increased to more than 20 h and the higher the expression
level, the longer the half life. Meanwhile, the processing of
the endogenous optineurin also appeared to be affected (Fig. 8C).
The mechanisms underlying these intriguing findings are un-
clear. The inducible cell lines established are anticipated to
provide a valuable model system for such studies and for others
including gene expression alterations subsequent to optineurin
overexpression.
RGC5, an immortalized RGC cell line established by
transforming postnatal day 1 rat retinal cells with E1A adenovirus
[39], has been used widely and extensively as a model of RGC for
various investigations [24,40]. It is of note however, that very
recently a re-characterization of the RGC5 cells led to the
revelation that they were in fact of mouse, not rat origin by both
mitochondrial and nuclear DNA analysis [41]. The cells were not
positive for known markers of ganglion cells such as neurofila-
ments or Thy1.2. Nevertheless, they did stain positively for
neuronal markers b-tubulin and PGP9.5, as well as for the
microtubule-associated protein, tau, and were able to differentiate
with neurite extensions after treatment of staurosporine [24,42] or
trichostatin A [43], suggesting that these cells still represent
neuronal precursor cells. We have repeated the results from RGC5
cells in RPE, human trabecular meshwork [17], and/or another
neuronal rat pheochromocytoma PC12 [44] cells (data not shown).
Taken together, the current study provides new evidence and
information, elucidating basic characteristics such as the glycosyl-
ation, phosphorylation and oligomerization status of optineurin.
This information is important for further efforts in defining
precisely how optineurin functions normally and how mutations
result in pathology.
In neurodegenerative disorders such as Alzheimer’s, Hunting-
ton’s and Parkinson’s, intracellular deposition of aggregated
proteins into inclusion bodies, Lewy bodies, or aggresomes is a
Figure 8. Turnover of endogenous and induced optineurin. A.
Turnover of the endogenous optineurin in RGC5 cells. The cells were
treated with cycloheximide (5 mg/ml) for 4 h to block the protein
synthesis, and were harvested at the indicated time points. Western
blotting for optineurin (OPTN) and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH, for loading control) was performed and
densitometry was carried out. The ratios between the level of
optineurin and that of GAPDH are presented. The half life of the
endogenous optineurin was determined to be approximately 8 h. B.
Turnover of optineurin-GFP (OPTN-GFP) in low expressers. C. Turnover
of optineurin-GFP (OPTN-GFP) in high expressers. The cells were treated
for 20 h with Dox (1 mg/ml) to express optineurin-GFP. After exposing
to cyclohexmide for 4 h, the lysates were collected at the indicated time
points. Anti-optineurin was used to detect both OPTN-GFP and the
endogenous optineurin (OPTN). Compared to RGC5 endogenous
optineurin (A), the induced optineurin-GFP had a delayed degradation
rate in both low and high expressers. The half life of optineurin-GFP was
approximately 20 h in low expressers. It was prolonged to .24 h in
high expressers.
doi:10.1371/journal.pone.0009168.g008
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proteins (such as a-synuclein in Parkinson’s) into Lewy bodies is
dependent on the microtubule-based dynein-dynactin pathway
[47]. Mimicking at the molecular level, optineurin also appears to
be an aggregate-prone protein with its foci formation contingent
on the integrity of the microtubule network. These similarities
further reinforce the notion that glaucoma shares common
features with neurodegenerative diseases [48,49] and support a
neurodegenerative paradigm for glaucoma.
Materials and Methods
Cell Lines
Rat RGC5 cells were obtained from the University of Illinois at
Chicago, Ophthalmology departmental core facility, deposited by
Dr. Paul Knepper [50] and originally from Dr. Neeraj Agarwal
[39]. In some experiments, RGC5 cells were differentiated with
316 nM staurosporine for 4 h [39]. Human RPE (ARPE 19) cells
were from American Type Cell Culture (Manassas, VA). The cells
were cultured in complete medium as previously described
[17,51].
DNA Constructs
Optineurin expression vectors pTarget-FLAG-wild type opti-
neurin (OPTN) and pOPTN-EGFP, as well as pRab8Q67L-EGFP
with constitutively active Rab8 (Rab8Q67L) fused to EGFP were
constructed as previously described [17]. pOPTN-His-pcDNA3.1z
was made by adding a His tag to the C-terminal of optineurin by
PCR using pOPTN-EGFP as the template and the subsequent
subcloning of OPTN-His into EcoR V linearized pcDNA3.1z
vector (Clontech, Mountain View, CA). pTfR-EGFP was made by
PCR amplification of full length TfR gene from human MGC
verified cDNA (clone ID 3354176, Open Biosystem, Huntsville,
AL) and subcloned into pEGFP-N1 (EcoR I-BamH I). Human
myosin VI full length fused to EGFP (pMyoVI-EGFP) was
generously provided by Dr. Tama Hasson, University of
California San Diego [52].
To generate inducible cell lines, a single Tet-on expression
vector pTRE-OPTN-EGFP-INS-rtTA-IRES-hyg-pcDNA3.1z
was created. Briefly, to produce pTRE-OPTN-EGFP construct,
OPTN-EGFP fusion gene was digested from pOPTN-EGFP and
cloned into EcoR I and BamH I linearized pTRE-tight vector
(Clontech). To construct pIRES-hyg-pcDNA3.1z, IRES (internal
ribosome entry site from virus EMCV) was digested from pBL-EP
(kindly provided by Dr. John Olsen, University of North Carolina)
by EcoR I and EcoR V and cloned into linearized pcDNA3.1z
vector. Hygromycin was then shuttled from the linearized
hygromycin marker (Clontech) to make pIRES-hyg-pcDNA3.1z.
Next, the 1.2 kb fragment of rtTA driven by CMV promoter was
digested with EcoR I and Hind III from plasmid pTet-on Advance
vector (Clontech), blunt ended and ligated with BamH I linearized
and blunt ended pIRES-hyg-pcDNA3.1z to result in prtTA-IRES-
hyg-pcDNA3.1z. The 3 kb TRE-OPTN-EGFP fragment was then
shuttled from pTRE-OPTN-EGFP to pBS II-SK(+) vector and the
1.2 kb fragment of 59-HS4 chicken b-globin insulator (INS) was
digested with Xba I from plasmid pJC13-1 (kindly provided by Dr.
Gary Felsenfeld, National Institute of Diabetes and Digestive
Diseases, Bethesda, MD) and ligated with Spe I linearized plasmid
pBS-TRE-OPTN-EGFP to generate pBS-TRE-OPTN-EGFP-
INS. Finally, the 4 kb fragment of rtTA-IRES-hyg was digested
with Bgl II and Pvu II from plasmid prtTA-IRES-hyg-
pcDNA3.1z, blunt ended and ligated with Sac II linearized and
blunt ended vector pBS-TRE-OPTN-EGFP-INS to construct
pTRE-OPTN-EGFP-INS-rtTA-IRES-hyg-pcDNA3.1z. Two dif-
ferent types of clones were selected with the two expression
cassettes oriented either in same or the opposite direction (Fig.
S1). Both clones, when transfected into RGC5 cells, induced
optineurin-GFP expression upon Dox treatment.
Immunohistochemistry
For localization of the endogenous optineurin, rat RGC5
without or with staurosporine treatment and human RPE cells
were washed with rinsing solution, fixed, blocked, and double
immunostained with rabbit polyclonal C-terminal or INT-
optineurin antibody (1:100, Cayman Chemical, Ann Arbor, MI)
and mouse monoclonal anti-GM130 (1:200, BD Biosciences, San
Jose, CA). FITC-goat anti-rabbit and Cy3-goat anti-mouse IgG
(1:200, Jackson ImmunoResearch, West Grove, PA) were used
as the secondary antibodies. RPE cells were stained with two
different optineurin antibodies (C-terminal, reactive to both
human and rat, and INT, reactive to human optineurin, amino
acid residues 115–130) while RGC5 cells were stained with only
the C-terminal antibody. Two different blocking solutions (3%
bovine serum albumin (BSA) and 10% normal goat serum) and
two rinsing solutions (phosphate buffered saline (PBS) with or
without 0.1 M glycine, pH 8.2) were used for the staining
procedure, and the staining results were compared side by side.
In negative controls, the primary antibodies were omitted and the
cells were incubated with only secondary antibodies. The slides
were mounted in Vectashield (Vector Laboratories, Burlingame,
CA) with 49,6-diamidino-2-phenylindole (DAPI).
In optineurin overexpression studies, cells were transfected [51]
for 20 h with pEGFP-N1 (mock control) or pOPTN-EGFP using
Lipofectamine LTX transfection reagent (Invitrogen, Carlsbad,
CA), fixed, and immunostained with mouse anti-GM130 (1:200),
anti-Rab8 (1:200, BD Biosciences), anti-myosin VI (1:200, Sigma,
St. Louis, MO), or anti-TfR (1:200, Zymed, South San Francisco,
CA).
In some experiments, RGC5 and RPE cells transfected with
pOPTN-EGFP for 20 h were untreated or treated with 10 mM
nocodazole (Sigma) for 30 min. They were then washed
thoroughly, and re-incubated in complete media for 1 h, fixed,
and stained with mouse anti-a-tubulin (1:200, BioGeneX, San
Ramon, CA).
Photography was carried out using a 636 oil objective on an
Axioscope (Carl Zeiss MicroImaging, Thornwood, NY) with the
aid of Metamorph software (Molecular Devices, Downingtown,
PA). In some experiments, confocal microscopic analysis was
performed on a Leica SP2 confocal system (Leica Microsystems,
Bannockburn, IL) using sequential scanning to minimize the bleed
through.
IP and Western Blotting
RGC5 cells were lysed with IP lysis buffer (250 mM NaCl,
50 mM Tris/HCl, pH 7.5, 5 mM EDTA, 0.5% Nonidet P40)
supplemented with protease inhibitor cocktail (Sigma). Protein
concentration was determined by bicinchoninic acid protein assay
(Pierce, Rockford, IL). The lysate was immunoprecipitated with
rabbit anti-optineurin (Bethyl Laboratories, Montgomery, TX) or
rabbit normal IgG (negative control) using the Catch and Release
kit (Millipore, Billerica, MA). The proteins pulled down were
subjected to SDS-PAGE under reducing conditions. The proteins
were transferred to nitrocellulose membrane using iBlot
TM gel
transfer device (Invitrogen). Phosphorylation of the proteins was
assessed by immunoblotting with mouse monoclonal anti-phos-
phoserine, anti-phosphothreonine (1:2,000, Sigma) and anti-
phosphotyrosine (1:1,000, PY20, BD Transduction laboratories,
San Jose, CA). Pulled down proteins were also immunoblotted
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confirm that optineurin protein was immunorecipitated. Immu-
noreactive optineurin bands were detected by chemiluminescence
using SuperSignal Substrate (Pierce).
Co-IP experiments were performed after co-transfecting RGC5
cells with pTarget-FLAG-OPTN and pOPTN-His-pcDNA3.1z
for 20 h. Rabbit anti-His polyclonal antibody (Santa Cruz
Biotechnology, Santa Cruz, CA) was used to immunoprecipitate
optineurin-His fusion protein from the lysates. The pulled down
proteins were then subjected to SDS-PAGE and Western blotting
with mouse anti-FLAG monoclonal antibody (Strategene, La Jolla,
CA).
Membrane Protein Extraction
RGC5 cells (5610
6) were washed with PBS and lysed in IP lysis
buffer. Total cell lysate was subjected to membrane protein
extraction using Mem-PER Eukaryotic Membrane Protein
Extraction Reagent kit (Pierce). Following a mild detergent-based
protocol, the hydrophobic proteins were separated from the
hydrophilic ones through a phase partitioning. Cross-contamina-
tion of cytosolic proteins into the membrane fraction is typically
,10%. The separated hydrophobic and hydrophilic fractions
were then subjected to SDS-PAGE and immunoblotted using
rabbit anti-C-terminal-optineurin or mouse anti-GM130 (used as
positive control for membrane protein).
Glycosylation
Total protein (50–100 mg) from RGC5 cells or those transfected
with pTarget-FLAG-OPTN was digested with PGNase F (0.25
units, Enzymatic In-Solution N-deglycosylation kit, Sigma) for N-
deglycosylation or with O-glycosidase (2.5 mUnits, Sigma) without
or with addition of sialidase A (5 mUnits, Sigma) for O-
deglycosylation per manufacturer’s instructions. Samples were
subjected to SDS-PAGE and Western blotted with rabbit anti-C-
terminal optineurin (1:2,000) to detect the endogenous optineurin
in RGC5 cells, or mouse anti-FLAG (1:5,000) to detect FLAG-
optineurin in transfected cells. The purified RNase B (Sigma) was
used as a positive control in parallel in the N-deglycosylation
experiment and the purified bovine fetuin (Sigma) as a positive
control in the O-deglycosylation experiment. These gels were
stained with Coomassie blue and scanned for documentation after
SDS-PAGE.
Native Blue Gel Electrophoresis
To examine the interaction of optineurin with itself, RGC5 cells
or those transfected with pTarget-FLAG-OPTN were lysed in IP
buffer and the lysates were subjected to native blue gel
electrophoresis. Total protein was mixed with 2x native sample
buffer (0.125 M Tris-HCl, pH 6.8, 20% glycerol, 0.01 mg/ml
bromphenol blue) and resolved on NativePAGE
TM NovexH Bis-
Tris Gel (Invitrogen) under nonreducing conditions. Protein bands
were transferred to nitrocellulose membrane and the endogenous
native optineurin band(s) was detected using rabbit anti-C-
terminal optineurin polyclonal antibody (1:2,000) and horseradish
peroxidase (HRP) conjugated goat anti-rabbit secondary antibody
(1:10,000, Jackson ImmunoResearch). FLAG-optineurin was
detected using mouse anti-FLAG monoclonal antibody (1:5000,
Stratagene, La Jolla, CA).
To investigate complex formation, RGC5 and RPE cells were
transfected either with pTarget-FLAG-OPTN alone or co-
transfected with pRab8Q67L-EGFP, pMyoVI-EGFP, pTfR-EGFP,
pRab8Q67L-EGFP + pMyoVI-EGFP, pRab8Q67L-EGFP + pTfR-
EGFP, pMyoVI-EGFP + pTfR-EGFP, or pRab8Q67L-EGFP +
pMyoVI-EGFP + pTfR-EGFP. Cell lysates were subjected to
native blue gel electrophoresis and Western blotting. The native
FLAG-optineurin bands were immunoprobed with mouse
anti-FLAG monoclonal antibody (1:2,000) and HRP conju-
gated goat anti-mouse secondary antibody (1:10,000, Jackson
ImmunoResearch).
Screening and Cloning of Tet-on Optineurin-GFP Stable
Cell Lines
RGC5 cells were transient transfected for 20 h with pTRE-
OPTN-INS-hyg-IRES-rtTA-CMVp or pTRE-OPTN-INS-CMVp
–rtTA-IRES-hyg construct in T-25flasks using LipofectamineLTX
transfection reagent. The growth medium was changed to selection
medium containing 100 mg/ml of hygromycin and the selection
continued for about 2 weeks until medium sized colonies grew out.
The cells were then trypsinized and induced with 1 mg/ml of Dox
for 24 h. Bright GFP positive cells were sorted using DakoCytoma-
tion MoFlo into 96 well plates (1 cell/well) with maintenance
medium (with 50 mg/ml of hygromycin but without Dox) for
another 2 weeks. Cells were screened for high or low optineurin-
GFP expression after induction with Dox by fluorescence
microscopy. The protein level of optineurin-GFP was assessed by
immunoblotting against polyclonal anti-optineurin and anti-glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH, Trevigen, Gai-
thersburg, MD). Both high and low expressers were allowed to
multiply and were subsequently banked in liquid nitrogen.
Turnover of Optineurin
To determine the turnover rate of the endogenous optineurin,
RGC5 cells were plated onto 6-well plates (1610
6 cells/well). After
incubation with medium containing 5 mg/ml of cycloheximide
(Calbiochem, Gibbstown, NJ) for 4 h, the cells were harvested at
0-, 2-, 4-, 6-, 8-, and 24-h time points similar to that described
previously [53,54]. Total protein (40 mg) from each sample was
subjected to Western blotting using rabbit anti-C-terminal
optineurin polyclonal antibody. The membrane was also im-
munoblotted for GAPDH as a loading control. Densitometry was
performed. The band intensity of the endogenous optineurin was
normalized to that of GAPDH. The half life of GAPDH is
reported to be longer than 72 h [55].
The turnover of optineurin-GFP in Tet-on high and low RGC5
expressers were determined after induction for 20 h with Dox and
a treatment for 4 h with cycloheximide. Proteins harvested from
cells 0, 4, 8, 16, 24, and 40 h later were immunoblotted with anti-
optineurin and anti-GAPDH. All experiments were repeated at
least 3 times.
Supporting Information
Figure S1 Single plasmid constructs with two expression
cassettes. The two cassettes (responsive element, in yellow, and
regulatory element, in blue) are separated by 59-HS4 chicken b-
globin insulator (INS, in pink). A shows the plasmid in which the
regulatory element is of the same orientation as the responsive
element. B shows the plasmid in which the regulatory element is of
the opposite orientation as the responsive element.
Found at: doi:10.1371/journal.pone.0009168.s001 (7.23 MB TIF)
Video S1 Movement of optineurin foci monitored by live cell
microscopy. A live RGC5 cell transfected to express optineurin-
GFP was imaged. Images were collected every 7 seconds for 7
minutes. Frame rate: 30 frames/2 seconds.
Found at: doi:10.1371/journal.pone.0009168.s002 (2.58 MB AVI)
Video S2 Long-distance movement of optineurin foci. A live
RPE cell transfected to express optineurin-GFP was imaged.
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Frame rate: 23 frames/second. A long-distance movement was
seen (arrow).
Found at: doi:10.1371/journal.pone.0009168.s003 (5.08 MB AVI)
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